| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/2002 | CA2118724C Detection method for c-raf-1 genes |
| 01/15/2002 | CA2089143C Growth factor compositions, preparation and use |
| 01/15/2002 | CA2036894C Vectors and compounds for expression of glycosylation mutants of human protein c |
| 01/15/2002 | CA2030951C Process for producing immunostimulant agents |
| 01/15/2002 | CA2022444C Lhrh analogs |
| 01/15/2002 | CA2001719C Phosphorylated fusion proteins and uses related thereto |
| 01/14/2002 | CA2352399A1 Crystal structure of the 30s ribosome and its use |
| 01/14/2002 | CA2352036A1 Crystal structure of antibiotics bound to the 30s ribosome and its use |
| 01/14/2002 | CA2312266A1 The use of hcarg, a novel calcium-regulated gene coding for a nuclear protein, for regulating cell proliferation |
| 01/10/2002 | WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 01/10/2002 | WO2002003063A1 Use of disease-associated gene |
| 01/10/2002 | WO2002003060A2 Process for the measurement of dinophysistoxin and of yessotoxin |
| 01/10/2002 | WO2002002824A1 Methods and assays for diagnosing alzheimer's disease |
| 01/10/2002 | WO2002002809A2 Diagnosis of behavioural disorders, neurological disorders and cancer |
| 01/10/2002 | WO2002002808A2 Method and nucleic acids for the analysis of astrocytomas |
| 01/10/2002 | WO2002002807A2 Diagnosis of diseases associated with cell signalling |
| 01/10/2002 | WO2002002806A2 Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics |
| 01/10/2002 | WO2002002804A1 Gene expression in biological conditions |
| 01/10/2002 | WO2002002789A2 Compositions and methods for producing recombinant virions |
| 01/10/2002 | WO2002002787A1 Elicitor from cladosporium |
| 01/10/2002 | WO2002002784A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002771A2 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
| 01/10/2002 | WO2002002770A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/10/2002 | WO2002002769A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | WO2002002768A1 A novel polypeptide, a human natriuretic peptide receptor 9 and the polynucloetide encoding the polypeptide |
| 01/10/2002 | WO2002002767A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/10/2002 | WO2002002765A2 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | WO2002002752A1 Attenuated bovine respiratory syncytial virus |
| 01/10/2002 | WO2002002751A2 Alteration of cell membrane |
| 01/10/2002 | WO2002002749A1 Transformed yeast for constructing combinatorial protein library |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002743A2 The nip3 family of proteins |
| 01/10/2002 | WO2002002738A2 Host cells containing multiple integrating vectors |
| 01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | WO2002002639A2 Human ion channels |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002637A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/10/2002 | WO2002002636A2 Membrane associated protein zupari |
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002632A2 Modulation of tetraspanin function |
| 01/10/2002 | WO2002002631A1 Structure-based drug design method to identify compounds that bind to cd81, a cell receptor for hepatitis-c |
| 01/10/2002 | WO2002002630A2 Hcn polypeptides and polynucleotides and their use in therapy |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002626A2 Novel secreted proteins |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002622A2 Crystal structure of survivin |
| 01/10/2002 | WO2002002621A2 Mammalian secreted proteins |
| 01/10/2002 | WO2002002620A2 Crmp-5 (collapsin response-mediator protein) encoding nucleic acid, polypeptide and uses thereof |
| 01/10/2002 | WO2002002619A1 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof |
| 01/10/2002 | WO2002002617A1 A novel polypeptide - human beta adducin 10 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002616A1 A novel polypeptide-gamma-cop13 and a polynucleotide encoding thesame |
| 01/10/2002 | WO2002002614A1 A novel polypeptide - human cytochrome c domain containing-tnfr/ngfr protein 14 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002613A1 A novel polypeptide - human oxysterol-binding protein 38.72 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002612A1 A novel polypeptide human - glutamate receptor interacting protein 11.55 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002611A1 A novel polypeptide-ribosomal protein l22 and speract repeat domain 12, and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002608A2 NEW SODIUM CHANNEL (rNaV1.5a) AND USE THEREOF |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002606A2 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | WO2002002604A2 Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002602A2 Slgp protein and nucleic acid molecules and uses therefor |
| 01/10/2002 | WO2002002601A2 Mutant presenilin 1 and presenilin 2 polypeptides |
| 01/10/2002 | WO2002002600A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF |
| 01/10/2002 | WO2002002599A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF |
| 01/10/2002 | WO2002002598A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR18, AND USES THEROF |
| 01/10/2002 | WO2002002597A2 Peptide extended glycosylated polypeptides |
| 01/10/2002 | WO2002002594A1 Peptide for swine pregnancy test reagents and swine pregnancy test reagents |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002590A2 I-superfamily conotoxins |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002586A1 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 01/10/2002 | WO2002002580A2 Haplotypes of the etfb gene |
| 01/10/2002 | WO2002002147A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | WO2002002142A1 Papillomavirus vaccine |
| 01/10/2002 | WO2002002136A1 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 01/10/2002 | WO2002002133A2 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 01/10/2002 | WO2002002132A1 Chemokine conjugates |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002001950A2 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | WO2001070930A3 Growth factor binding molecules |
| 01/10/2002 | WO2001070813A3 REGULATION OF HUMAN GluR5-LIKE RECEPTOR |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001068830A8 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 01/10/2002 | WO2001060404A3 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 01/10/2002 | WO2001055334A8 Methods and materials relating to immunoglobulin domain-containing polypeptides and polynucleotides |
| 01/10/2002 | WO2001055307A3 Nucleic acids, proteins, and antibodies |
| 01/10/2002 | WO2001053349A3 Small cell lung cancer associated antigens and uses therefor |
| 01/10/2002 | WO2001052900A3 Novel orthogonally protected amino acid chelators for biomedical applications |
| 01/10/2002 | WO2001049848A3 Nucleic acids and polypeptides of drosophila melanogaster snf sodium- neurotransmitter symporter family cell surface receptors and methods of use |
| 01/10/2002 | WO2001049708A3 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 01/10/2002 | WO2001048483A3 Method for screening of appetite control agents |
| 01/10/2002 | WO2001048145A3 High affinity tcr proteins and methods |